Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy
Author(s) -
Kenneth E. Schmader,
Michael N. Oxman,
Myron J. Levin,
Gary R. Johnson,
J. H. Zhang,
Robert F. Betts,
V. A. Morrison,
Lawrence Gelb,
J C Guatelli,
Ruth Harbecke,
C. T. Pachucki,
S. Keay,
Barbara E. Menzies,
Marie R. Griffin,
Carol A. Kauffman,
Adriana Marques,
John Toney,
Paul M. Keller,
X. Li,
I. S. F. Chan,
Paula W. Annunziato
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis638
Subject(s) - persistence (discontinuity) , shingles , medicine , term (time) , virology , virus , geotechnical engineering , engineering , physics , quantum mechanics
The Shingles Prevention Study (SPS; Department of Veterans Affairs Cooperative Study 403) demonstrated that zoster vaccine was efficacious through 4 years after vaccination. The Short-Term Persistence Substudy (STPS) was initiated after the SPS to further assess the persistence of vaccine efficacy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom